NEWS

For our visitors who seek the latest industry news and updates to keep up with the goings-on of the business on a global scale, this portal grants a dynamic and diverse feed of news items contemporaneous with the current affairs of the Pharmaceutical Industry.

news

Strides Shasun Ltd Clarifies on news item on recommendation by European Medicines Agency (EMA) for suspension of 300 drugs. Co has only one drug in 5 markets and said product has not been commercialized. Co confirms that recommendation will not have any impact on operations and financials of co.  …

news

Drug major Sun Pharmaceutical Industries today said Spain-based Almirall S.L has sought regulatory approval from the European Medicines Agency for a new drug, tildrakizumab. The drug is being evaluated for the treatment of moderate-to-severe plaque psoriasis, the two companies said in a statement. In July 2016, Almirall entered into a…

news

Eli Lilly and Co said on Friday it would invest $850 million in its U.S. operations this year, and the drugmaker signaled it would be willing to spend more if the Trump administration were to overhaul tax laws. Lilly said investments would be made in research laboratories and manufacturing sites,…

news

Botanix Pharmaceuticals Ltd Receives export and import approvals for clinical studies. U.S. Drug Enforcement Agency approved export, Australian Office Of Drug Control approved import of synthetic cannabidiol for planned clinical studies.   Source: reuters.com

news

U.S. health regulators on Thursday approved a drug developed by Merck KGaA and Pfizer Inc that helps the immune system to fight a rare form of skin cancer once it has spread to other parts of the body. The Food and Drug Administration said it approved Bavencio, known chemically as…

news

Ultragenyx Pharmaceutical Inc said its drug to treat patients with seizures did not meet the main goal in a mid-stage study, sending its shares down 6.2 percent in after-market trading on Wednesday. The company said the study did not show statistical significance in reducing the frequency of seizures among patients…

news

Novartis's heart failure drug serelaxin flopped in a late-stage trial by not cutting cardiovascular death or slowing disease progression, marking the likely demise of a drug hopeful the Swiss firm had promoted as a potential blockbuster. The company's shares fell as much as 2.2 percent following the announcement on Wednesday,…

news

Generic drugmaker Mylan NV has recalled about 81,000 EpiPen devices in countries outside the United States, following two reports of the life-saving allergy shot failing to work in emergencies. In both situations, patients were able to obtain treatment through the use of an alternate EpiPen, Mylan said on Wednesday. The…

news

Sanofi SA and Regeneron Pharmaceuticals Inc have filed a lawsuit seeking a court order declaring that their eczema drug Dupixent, awaiting a U.S. approval decision, does not infringe an Amgen Inc patent for a failed asthma treatment. The lawsuit, filed in federal court in Boston on Monday, was intended to…

news

Newron Pharmaceuticals SpA said on Tuesday the U.S. Food and Drug Administration approved its Parkinson's disease treatment Xadago as an add-on therapy to levodopa, a drug widely used to treat the disease. Levodopa was developed in the late 1960s and is the first-line treatment for the management of Parkinson's, according…